The Insider: Deep Tech Partners Edition—April 2026
Featured News
С»ÆÊé Boulder and Techstars announce partnership to accelerate Colorado’s entrepreneurial ecosystem
The University of Colorado Boulder and Techstars, the global startup accelerator and investor, have announced a strategic partnership to expand opportunities for founders and strengthen Colorado’s innovation economy.
Opportunities for Partnership
Move your innovation forward with funding support from the Center for Translational Research
The Center for Translational Research (CTR), helps researchers and startup founders at С»ÆÊé Boulder, as well as external partners, to secure non-dilutive funding (financial support that does not require giving up equity) and advance promising technologies toward the marketplace. This year, the center welcomes new director Sarah Hughes.
University Startup and Innovation News
Thank you, Susan Strong—and happy retirement
Susan Strong has made lasting impacts across the University of Colorado Boulder and the larger Colorado innovation ecosystem.
Python blood could hold the secret to healthy weight loss
С»ÆÊé Boulder Today—С»ÆÊé Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The research, a collaboration with scientists at Stanford Medicine and Baylor universities, could inform new weight loss therapies that promote satiety without the nausea and muscle loss that can come with existing drugs.
A simple shot shows promise to reverse osteoarthritis within weeks
The New York Times, С»ÆÊé Boulder Today—A research team of scientists and engineers from the University of Colorado Boulder, University of Colorado Anschutz Medical Campus and Colorado State University has developed a suite of therapies that prompt aging or damaged joints to repair themselves within weeks, according to animal studies. The Advanced Research Projects Agency for Health (ARPA-H) has advanced the up to $33.5M project to its next phase, and the team has formed Renovare Therapeutics Inc. to move toward commercialization.
